Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The crossroads of cancer therapies and clonal hematopoiesis.

Seminars in hematology - 1 Feb 2024

Singh Abhay, Balasubramanian Suresh

Abstract excerpt

The intricate interplay between Clonal Hematopoiesis (CH) and the repercussions of cancer therapies has garnered significant research focus in recent years. Previously perceived as an age-related phenomenon, CH is now closely linked to inflammation ("Inflammaging") and cancer, impacting leukemogenesis, cancer progression, and treatment responses. This review explores the complex interplay between CH and diverse...

Topics

Join the communities discussing this publication.

TET2 gene
TP53 gene
Clonal Hematopoiesis
DNMT3A gene
Hematopoiesis
Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Receptors, Chimeric Antigen

Source

Identifiers

PMID: 38403501
DOI: 10.1053/j.seminhematol.2024.01.006

Genes

DNMT3A
PPM1D
TET2
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The crossroads of cancer therapies and clonal hematopoiesis.PMID 38403501Read ↗

Factors associated with clonal hematopoiesis and interaction with marrow environment.Semantic proximity Read ↗

Clonal hematopoiesis and its progression to myeloid neoplasms: insights into risk, biology, and therapeutic strategies.Semantic proximity Read ↗

The interplay of clonal hematopoiesis and cancer: Clinical implications in oncology.Semantic proximity Read ↗

Genetic and environmental risks for clonal hematopoiesis and cancer.Semantic proximity Read ↗

Ontogeny and Natural History of Therapy-Related Clonal Hematopoiesis From a Multidisciplinary CHIP Clinic.Semantic proximity Read ↗

Clonal hematopoiesis in patients with cancer and cancer survivors: From clonal burden to cardiovascular diseases.Semantic proximity Read ↗

Therapy-related myeloid neoplasms: when genetics and environment collide.Semantic proximity Read ↗

What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.Semantic proximity Read ↗

Distinct landscape and clinical implications of therapy-related clonal hematopoiesis.Semantic proximity Read ↗

Cancer therapy shapes the fitness landscape of clonal hematopoiesis.Semantic proximity Read ↗

Clonal hematopoiesis and risk for hematologic malignancy.Semantic proximity Read ↗

Elevated Clonal Hematopoiesis in 9/11 First Responders Has Distinct Age-related Patterns and Relies on IL1RAP for Clonal Expansion.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.